PJ Anand, Alcyone Therapeutics CEO
A gene therapy biotech is bursting onto the scene with 12 programs in tow. An ultra-rare neuro disease is up first
In downtown Lowell, MA, tucked into one of the country’s oldest surviving textile mill complexes is a new biotech toiling away on next-gen CNS therapies …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
